281 related articles for article (PubMed ID: 18093987)
1. PARP1 is required for adhesion molecule expression in atherogenesis.
von Lukowicz T; Hassa PO; Lohmann C; Borén J; Braunersreuther V; Mach F; Odermatt B; Gersbach M; Camici GG; Stähli BE; Tanner FC; Hottiger MO; Lüscher TF; Matter CM
Cardiovasc Res; 2008 Apr; 78(1):158-66. PubMed ID: 18093987
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of PARP inhibition on vascular cell survival and ACAT-1 expression favouring atherosclerotic plaque stability.
Hans CP; Zerfaoui M; Naura AS; Catling A; Boulares AH
Cardiovasc Res; 2008 Jun; 78(3):429-39. PubMed ID: 18245064
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-ribose) polymerase 1 activation is required for cisplatin nephrotoxicity.
Kim J; Long KE; Tang K; Padanilam BJ
Kidney Int; 2012 Jul; 82(2):193-203. PubMed ID: 22437413
[TBL] [Abstract][Full Text] [Related]
6. Thieno[2,3-c]isoquinolin-5-one, a potent poly(ADP-ribose) polymerase inhibitor, promotes atherosclerotic plaque regression in high-fat diet-fed apolipoprotein E-deficient mice: effects on inflammatory markers and lipid content.
Hans CP; Zerfaoui M; Naura AS; Troxclair D; Strong JP; Matrougui K; Boulares AH
J Pharmacol Exp Ther; 2009 Apr; 329(1):150-8. PubMed ID: 19124646
[TBL] [Abstract][Full Text] [Related]
7. Poly (ADP-Ribose) polymerase inhibition attenuates atherosclerotic plaque development in ApoE-/- mice with hyperhomocysteinemia.
Xie JJ; Yu X; Liao YH; Chen J; Yao R; Chen Y; Liao MY; Ding YJ; Tang TT; Cheng X
J Atheroscler Thromb; 2009 Oct; 16(5):641-53. PubMed ID: 19776495
[TBL] [Abstract][Full Text] [Related]
8. Interaction between inducible nitric oxide synthase and poly(ADP-ribose) polymerase in focal ischemic brain injury.
Park EM; Cho S; Frys K; Racchumi G; Zhou P; Anrather J; Iadecola C
Stroke; 2004 Dec; 35(12):2896-901. PubMed ID: 15514191
[TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-ribose) polymerase 1 inhibition protects against low shear stress induced inflammation.
Qin WD; Wei SJ; Wang XP; Wang J; Wang WK; Liu F; Gong L; Yan F; Zhang Y; Zhang M
Biochim Biophys Acta; 2013 Jan; 1833(1):59-68. PubMed ID: 23085506
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase 1 (PARP1) in atherosclerosis: from molecular mechanisms to therapeutic implications.
Xu S; Bai P; Little PJ; Liu P
Med Res Rev; 2014 May; 34(3):644-75. PubMed ID: 24002940
[TBL] [Abstract][Full Text] [Related]
11. Poly(ADP-ribose) polymerase 1 deficiency increases nitric oxide production and attenuates aortic atherogenesis through downregulation of arginase II.
Wei SJ; Cheng L; Liang ES; Wang Q; Zhou SN; Xu H; Hui LH; Ge ZM; Zhang MX
Clin Exp Pharmacol Physiol; 2017 Jan; 44(1):114-122. PubMed ID: 27757983
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of poly (ADP-ribose) polymerase and inducible nitric oxide synthase protects against ischemic myocardial damage by reduction of apoptosis.
Wang J; Hao L; Wang Y; Qin W; Wang X; Zhao T; Liu Y; Sheng L; Du Y; Zhang M; Lu Q
Mol Med Rep; 2015 Mar; 11(3):1768-76. PubMed ID: 25412407
[TBL] [Abstract][Full Text] [Related]
13. Role of poly(ADP-ribose) polymerases in the regulation of inflammatory processes.
Bai P; Virág L
FEBS Lett; 2012 Nov; 586(21):3771-7. PubMed ID: 23022557
[TBL] [Abstract][Full Text] [Related]
14. Expression of adhesion molecular proteins in the cochlear lateral wall of normal and PARP-1 mutant mice.
Shi X; Nuttall AL
Hear Res; 2007 Feb; 224(1-2):1-14. PubMed ID: 17184942
[TBL] [Abstract][Full Text] [Related]
15. Loss of poly(ADP-ribose) polymerase 1 attenuates renal fibrosis and inflammation during unilateral ureteral obstruction.
Kim J; Padanilam BJ
Am J Physiol Renal Physiol; 2011 Aug; 301(2):F450-9. PubMed ID: 21613422
[TBL] [Abstract][Full Text] [Related]
16. PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.
Mukhopadhyay P; Horváth B; Rajesh M; Varga ZV; Gariani K; Ryu D; Cao Z; Holovac E; Park O; Zhou Z; Xu MJ; Wang W; Godlewski G; Paloczi J; Nemeth BT; Persidsky Y; Liaudet L; Haskó G; Bai P; Boulares AH; Auwerx J; Gao B; Pacher P
J Hepatol; 2017 Mar; 66(3):589-600. PubMed ID: 27984176
[TBL] [Abstract][Full Text] [Related]
17. The role of poly(ADP-ribose) polymerase-1 inhibitor in carrageenan-induced lung inflammation in mice.
Ahmad SF; Zoheir KM; Ansari MA; Korashy HM; Bakheet SA; Ashour AE; Al-Shabanah OA; Al-harbi MM; Attia SM
Mol Immunol; 2015 Feb; 63(2):394-405. PubMed ID: 25304310
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy.
Qin WD; Liu GL; Wang J; Wang H; Zhang JN; Zhang F; Ma Y; Ji XY; Li C; Zhang MX
Oncotarget; 2016 Jun; 7(24):35618-35631. PubMed ID: 27027354
[TBL] [Abstract][Full Text] [Related]
19. Minocycline reduces plaque size in diet induced atherosclerosis via p27(Kip1).
Shahzad K; Thati M; Wang H; Kashif M; Wolter J; Ranjan S; He T; Zhou Q; Blessing E; Bierhaus A; Nawroth PP; Isermann B
Atherosclerosis; 2011 Nov; 219(1):74-83. PubMed ID: 21719015
[TBL] [Abstract][Full Text] [Related]
20. Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast.
Perkins E; Sun D; Nguyen A; Tulac S; Francesco M; Tavana H; Nguyen H; Tugendreich S; Barthmaier P; Couto J; Yeh E; Thode S; Jarnagin K; Jain A; Morgans D; Melese T
Cancer Res; 2001 May; 61(10):4175-83. PubMed ID: 11358842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
